Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Braspenning

Showing results (91-100 of 199) with videos related to

Pageof 20
Sort By:
Journal of Medical Internet Research|June 10, 2025
Collaborating Across Organizational Boundaries to Develop, Evaluate, and Implement eHealth: Scoping ReviewAafke G Coopmans, Remco S Mannak, Anna M Braspenning, et al.
Family Practice|November 16, 2007
The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorderMirrian Smolders, Miranda Laurant, Eric van Rijswijk, et al.
Scandinavian Journal of Primary Health Care|May 17, 2025
What makes patients in primary care complex? A scoping review combined with a focus group analysisJozé Braspenning, Rachel van den Kieboom, Erik W M A Bischoff, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2016
Inter-practice variation in polypharmacy prevalence amongst older patients in primary careJudith Sinnige, Jozé C Braspenning, François G Schellevis, et al.
The Netherlands Journal of Medicine|February 13, 2007
Clinical indicators: development and applicationsH Wollersheim, R Hermens, M Hulscher, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2017
[Inter-practice variation in polypharmacy prevalence amongst older patients in primary care]J Sinnige, J C Braspenning, F G Schellevis, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Evaluation of quality indicators for Dutch community pharmacies using a comprehensive assessment frameworkTim W A Schoenmakers, Martina Teichert, Jozé Braspenning, et al.
Oncogene|March 31, 1998
The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cellsJ Braspenning, A Marchini, V Albarani, et al.
Preventive Medicine|November 28, 2002
Patient characteristics determine differences in the influenza vaccination rate more so than practice featuresMargot Tacken, Jozé Braspenning, Peter Spreeuwenberg, et al.
Pharmacology Research & Perspectives|October 31, 2015
Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studiesSarada D Ramachandran, Aurélie Vivarès, Sylvie Klieber, et al.
Pageof 20

Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
Journal of Medical Internet Research|June 10, 2025
Collaborating Across Organizational Boundaries to Develop, Evaluate, and Implement eHealth: Scoping ReviewAafke G Coopmans, Remco S Mannak, Anna M Braspenning, et al.
Family Practice|November 16, 2007
The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorderMirrian Smolders, Miranda Laurant, Eric van Rijswijk, et al.
Scandinavian Journal of Primary Health Care|May 17, 2025
What makes patients in primary care complex? A scoping review combined with a focus group analysisJozé Braspenning, Rachel van den Kieboom, Erik W M A Bischoff, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2016
Inter-practice variation in polypharmacy prevalence amongst older patients in primary careJudith Sinnige, Jozé C Braspenning, François G Schellevis, et al.
The Netherlands Journal of Medicine|February 13, 2007
Clinical indicators: development and applicationsH Wollersheim, R Hermens, M Hulscher, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2017
[Inter-practice variation in polypharmacy prevalence amongst older patients in primary care]J Sinnige, J C Braspenning, F G Schellevis, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Evaluation of quality indicators for Dutch community pharmacies using a comprehensive assessment frameworkTim W A Schoenmakers, Martina Teichert, Jozé Braspenning, et al.
Oncogene|March 31, 1998
The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cellsJ Braspenning, A Marchini, V Albarani, et al.
Preventive Medicine|November 28, 2002
Patient characteristics determine differences in the influenza vaccination rate more so than practice featuresMargot Tacken, Jozé Braspenning, Peter Spreeuwenberg, et al.
Pharmacology Research & Perspectives|October 31, 2015
Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studiesSarada D Ramachandran, Aurélie Vivarès, Sylvie Klieber, et al.
Pageof 20